Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Bullboard Posts
Post by JamJam123on May 04, 2017 8:11pm
163 Views
Post# 26206231

More coverage...

More coverage...

While the cannabis industry is still blooming, so are the companies’ investors need to watch.  This is especially true for Canadian cannabis stocks, where the Country’s political culture is already moving to nationwide legalization.

A front-runner in Canada’s cannabis industry is ABcann Global (TSX.V: ABCN), which was approved by Health Canada in 2012 to become a licensed producer in the medicinal cannabis sector.   ABcann Global (TSX.V: ABCN) has developed a computer-controlled growing system that produces high-quality, pesticide-free cannabis in an efficient manner and while that may not sound like much, think again.   Efficiency in production and quality control means better production of a higher quality product for less, on a per gram basis of cost.

 

From a medicinal perspective, quality controlled production means cannabis products that can be relied upon for purity, which is a huge factor from both medicinal distribution, retail and consumer outlooks.  That is the crux of ABcann Group’s value for investors.

The industry average in yield per square foot of production space is 125 grams.  ABcann Global (TSX.V: ABCN) boasts 250 grams per square foot, or nearly TWICE THE PRODUCTION rate.   As we already pointed out, that means higher returns for investors!

ABcann Global (TSX.V: ABCN) first production facility is online and consists of a 14,500-square foot facility in Ontario with an annual production capacity of 100kg.   A second 71,000 square foot facility is under development with a forecast annual production capacity of 20,000kg – that equates to CA$10 million in potential revenue.

The two locations can be seen in the picture on the left.   The existing facility in the bottom and the land designated for the much larger, commercial growing facility in the upper-right.   I should point out that ABcann Global (TSX.V: ABCN) already owns the land slated for Facility No. 2.

Readers can find out more about ABcann Global (TSX.V: ABCN) by downloading the company’s Corporate Presentation.

We should point out that ABcann Global isn’t trading as yet, but look for a Canadian Stock Exchange listing or IPO shortly!

Bullboard Posts